Navigation Links
Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
Date:9/19/2007

REINACH and BASEL, Switzerland, September 19 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) presented a large body of preclinical and clinical data on its investigational drug iclaprim at the 47th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. ICAAC is a major scientific conference where thousands of scientists and clinicians from all over the world gather to discuss the latest developments in the field of infectious diseases.

Iclaprim is a novel late stage investigational antibiotic which exhibits potent activity against Gram-positive bacteria including those resistant to current therapies, e.g., MRSA, VISA, VRSA etc. In three separate efficacy trials, iclaprim has been compared against either linezolid or vancomycin and has consistently shown high clinical cure rates. Moreover, clinical experience to date shows that iclaprim is well-tolerated in patients and volunteers. New data presented at ICAAC included large surveillance studies on recent clinical isolates, quality control and CLSI parameters for susceptibility testing, Phase I pharmacokinetic studies and results from the first pivotal Phase III clinical trial (ASSIST-1).

L-1142: ASSIST-1 data on microbiological efficacy in complicated Skin and Skin Structure Infections (cSSSI). Iclaprim showed high microbiological eradication rates against major cSSSI pathogens, comparable with linezolid (MRSA eradication rates were 84.7% vs. 85.3%, respectively). Additional clinical data on safety and efficacy will be presented in October at the upcoming IDSA meeting in San Diego.

E-902, E-904, E-910, E-911: Four posters presented data on large susceptibility studies against recent clinical isolates: iclaprim was the most active compound tested in a study against community-acquired and nosocomial Staphylococcus aureus (poster E-904) and it showed good activity against streptococci and enterococci.

E-906: Iclaprim exhibited rapid bactericidal activi
'/>"/>

SOURCE Arpida Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference
4. BioRobot MDx standardize your automated protocols in clinical laboratories
5. What patients want: A story of choice, clinical trials & evidence-based medicine
6. ZyStor seeks to raise $15M for clinical trials
7. Prodesse begins clinical trials for flu virus detection
8. ConjuGon raises $3.3 million to fund clinical trials
9. Cancer-fighting agent heads for clinical trials
10. Quintessence cancer treatment chosen for clinical studies
11. Third Wave reports clinical growth, continued loss

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., OMAHA, Neb., Nov. 5 ...y announced financial results for the quarter ende...lts are presented in the tables that follow. ,,... net loss of $366,000 or $0.01 per share for the t...$499,000 or $0.01 per share for the third quarter ...
(Date:11/5/2009)..., FORT WORTH, Texas, Nov. 5 /PRNewswire-FirstCal... announced today that it has entered into a Letter...ts of Virtual Health Technologies, Inc. (OTC Bulle... paid $1,000,000 in cash and debt, 4,000,000 share...erated by WNDM on the Veriscrip technology being a...
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSmi...enOsteo, Inc. to co-develop a unique scaffold that... Following evaluation of several commercial produc...ment, the company believes the GenOsteo scaffold r...that creates a unique and ideal environment for th...
(Date:11/5/2009)... LASIK Surgery and vision c...eons directory were actively involved at the recen...AO) 2009 Annual Meeting in San Francisco, Californ...er, MD, Dr. Jonathan Davidorf, MD, Dr. Peter Rapoz..., MD, Dr. R. Wayne Bowman, MD, Dr. Edward Manche, ...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...his summer, we looked at venture capital funding i... reached about $5 billion in investments in small ...r than the $5.4 billion invested during the fourth...per,s MoneyTree analysis. , ,The results for the ...ocker as venture capital investments achieved a tw...
... cells. Source: Office of U.S. Rep. Jane Harman (D...nic stem cells Democratic or Republican? , ,As sil...re of one of the more lamentable wedge issues of t...ies will deserve some blame if stem cell science t...followed the Democratic National Convention a few ...
...-- What,s more important to a manufacturing compan...in-Madison Center for Quick Response Manufacturing...t products developed and produced is seen as the b...guessed it money. , ,"It,s not usually about buyi...of the center, said at a seminar Wednesday morning...
Other Biology Technology:Midwest life science companies capture 3% of VC investments in Q.2 2Dividing stem cells along partisan lines isnt a good experiment 2Dividing stem cells along partisan lines isnt a good experiment 3University center offers speed boost to manufacturers 2
(Date:11/8/2009)...TS WITH INTELLECTUAL DISABILITIES: AN OPPORTUNITY ...dy involving adults with intellectual disabilities...alth knowledge after taking a semi-weekly class fo...lly accepted term for mental retardation, have sli... and preventable chronic diseases compared to the ...
(Date:11/6/2009)...burn Hills, MI-based Law Enforcement Intelligent D...ystem and patent-pending Biometric Access Control ... and Human Services, National Institutes of Health...ill support the NIH,s entire police force that is ...search agency. The project is expected to be comp...
(Date:11/5/2009)... a training grant in the amount of $2,756,719 by t...ve Graduation Education and Research Training (IGE...warded to Kent State. The grant, which is funded u... 2009, runs through 2014. , The grant funds an I...esource sensing (EARS). The purpose of the program...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers 48784 1Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers 48784 2Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers 48784 3Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers 48784 4Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers 48784 5Sleep Training Provides Much Needed Shut Eye 48780 1Sleep Training Provides Much Needed Shut Eye 48780 2New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 48776 1New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 48776 2New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 48776 3
...ick,s horticultural research arm Warwick HRI have ...nt DNA that will provide a massive boost to the wo... libraries is the largest of its type in the world...ce. , The Warwick researchers have set up a new sp...mited" to develop this powerful new resource for p...
...rapy for breast cancer , A team from the Universi...at by using a cancer vaccine based on the bacteriu...established breast tumors. Cancer vaccines, which ... by boosting an immune response against tumor-asso...s, led by Yvonne Paterson, PhD, Professor of Micro...
...by biologists at New York University,s Center for ...with researchers at Harvard University, the Max Pl...out a preliminary molecular diagram of the early s...time a global look at how a single cell begins its... are reported in the August 11 issue of the journa...
Other Biology News:New plant DNA libraries provides massive boost to world's plant researchers 2Breast tumors in mice eradicated using cancer vaccine 2Breast tumors in mice eradicated using cancer vaccine 3NYU biologists map out early stages of embryo formation 2
...ed immunospot) Kit analyzes interferon gamma (IFN&...t forms at the site where secreted cytokine is bou...pe or automated ELISPOT reader) and then compared ...is allows the frequency of cells secreting the cyt...
Corning Roller Bottle Easy Grip Caps, Sterile from Sigma-Aldrich
...ng Asuragens bioinformatics expertise. We offer th...data analysis using the most up to date methods. U...Expression Profiling Service or from your own micr...statistical analysis including publication quality...
CORNING 1700CM2 ROLLER BOTTLE, EASY GRIP CAP, GRADUATED, STERILE from Sigma-Aldrich
Biology Products: